The operation starts tomorrow: the HMOs will start vaccinating more than 60-year-olds tomorrow morning with a fourth vaccine

Adults and medical staff who have passed four months since receiving the third vaccine against Corona will be able to reach the HMOs for the dose.

Tonight, the director general of the Ministry of Health approved the move following the recommendation of the team of experts, and Bennett welcomed the decision. Meanwhile, the home drug treatment system also began to operate

Meirav Cohen

02/01/2022

Sunday, 02 January 2022, 22:36 Updated: 23:11

• Share on Facebook

• Share on WhatsApp

• Share on Twitter

• Share on Email

• Share on general

• Comments

  Comments

In the video: Bennett: "Fourth vaccine approved for adults over 60 (Photo: GPO)

The four HMOs will open tomorrow morning (Monday) the fourth vaccination campaign against Corona for those over 60 and the medical staff.

However, following the decision of the Director General of the Ministry of Health, Dr. Nachman Ash, to approve the recommendation of the staff handling epidemics issue given two weeks ago. Prime Minister Naftali Bennett welcomed this evening the decision of the Ministry of Health, said that it has great significance for curbing the wave of disease present.

Headquarters The Maccabi HMO has already opened the possibility of scheduling an appointment for the vaccine, and Clalit, Meuhedet and Leumit will allow this starting tomorrow. "The decision on the fourth vaccine is given during a fifth wave of illness, with the peak probably still ahead of us.

I call on everyone who has passed the age of 60 and four months have passed since the date of receiving the third dose of vaccine to go out and get vaccinated, thus preventing serious illness. "

More on Walla!

Enough for Corona!

Release the herd

To the full article

The fourth vaccination operation at Sheba Medical Center in Tel Hashomer, last week (Photo: Reuven Castro)

"The decision was made according to the best medical considerations," Bennett said.

"This is a new layer of protection. The policy of Rishonim in the world has protected Israeli citizens. Mortality in Israel recently is among the lowest in the world. In Britain mortality is 50 times greater. In the United States 130 times. We must not be complacent, I call on everyone who is entitled to a fourth dose - get vaccinated. That our profit taught us about the omicron. "

Bennett added in a statement issued by his office in Jerusalem that at the height of the wave of morbidity of the Omicron strain, the 50,000 verified line may be crossed per day.

"The good news is that we have learned from the world that if you are vaccinated as required you are largely protected even if you become infected," he said.

"Fears of corona damage are greater."

Patient Eva Rosenzweig with the drug, last night (Photo: courtesy of those photographed)

More on Walla!

• For the first time in Israel: HMOs have begun treating Korona patients with medication

• The Ministry of Health has approved a medicine for corona patients in a mild-moderate condition

• Due to the growing demand for effective treatment of pain, without side effects: B-Cure laser in a special operation

Medication began

Meanwhile, the HMOs began providing home medicine for the first time tonight to Corona patients in a mild-moderate condition.

This, using the drug Paxlobide manufactured by Pfizer.

It has an efficiency of about 90% in preventing hospitalizations and deaths among high-risk populations.

Four Maccabi HMO members have already received the medicine at home after they were found suitable for treatment by their doctors.

One of them is Ora Rosenzweig, a resident of Ramat Hasharon.

"There was great excitement ahead of the arrival of the drug," she said.

"I did three vaccines and still got Corona. Because I have a background I am very worried that my condition will get worse and I will get to the hospital. This drug gives me hope that I can get through Corona relatively easily. Even if there are some concerns about the drug, Corona damage is greater. ".

The purpose of the medication is to prevent serious illness and hospitalizations.

Corona Department at Sheba Tel Hashomer Medical Center, October (Photo: Reuters)

"The peak is probably still ahead of us."

Bennett at the press conference, last night (Photo: Paul, Emil Salman)

Hours earlier, the Ministry of Health had approved MSD's anti-viral drug MSN's antiretroviral drug, according to the Corona virus' headquarters.

The Ministry of Health's approval came after the drug was approved last week in an emergency approval by the FDA, and it is expected to arrive in Israel in the coming days.

Its mechanism of action, designed to create errors in the genetic code of the virus and thus prevent its further replication, is not expected to be affected by the variant type of the corona virus, and is therefore also relevant in view of the spread of the omicron variant.

• news

• Corona

Tags

• Corona

• Omicron variant

• Vaccine for corona